» Articles » PMID: 25168025

Nonmuscle Myosin II Regulates the Morphogenesis of Metanephric Mesenchyme-Derived Immature Nephrons

Overview
Specialty Nephrology
Date 2014 Aug 30
PMID 25168025
Citations 17
Authors
Affiliations
Soon will be listed here.
Abstract

The kidney develops from reciprocal interactions between the metanephric mesenchyme and ureteric bud. The mesenchyme transforms into epithelia and forms complicated nephron structures, whereas the ureteric bud extends its pre-existing epithelial ducts. Although the roles are well established for extracellular stimuli, such as Wnt and Notch, it is unclear how the intracellular cytoskeleton regulates these morphogenetic processes. Myh9 and Myh10 encode nonmuscle myosin II heavy chains, and Myh9 mutations in humans are implicated in congenital kidney diseases and focal segmental glomerulosclerosis in adults. Here, we analyzed the roles of Myh9 and Myh10 in the developing kidney. Ureteric bud-specific depletion of Myh9 resulted in no apparent phenotypes, whereas mesenchyme-specific Myh9 deletion caused proximal tubule dilations and renal failure. Mesenchyme-specific Myh9/Myh10 mutant mice died shortly after birth and showed a severe defect in nephron formation. The nascent mutant nephrons failed to form a continuous lumen, which likely resulted from impaired apical constriction of the elongating tubules. In addition, nephron progenitors lacking Myh9/Myh10 or the possible interactor Kif26b were less condensed at midgestation and reduced at birth. Taken together, nonmuscle myosin II regulates the morphogenesis of immature nephrons derived from the metanephric mesenchyme and the maintenance of nephron progenitors. Our data also suggest that Myh9 deletion in mice results in failure to maintain renal tubules but not in glomerulosclerosis.

Citing Articles

Measurement of adhesion and traction of cells at high yield reveals an energetic ratchet operating during nephron condensation.

Liu J, Prahl L, Huang A, Hughes A Proc Natl Acad Sci U S A. 2024; 121(39):e2404586121.

PMID: 39292750 PMC: 11441508. DOI: 10.1073/pnas.2404586121.


OLFM4 promotes the progression of intestinal metaplasia through activation of the MYH9/GSK3β/β-catenin pathway.

Wei H, Li W, Zeng L, Ding N, Li K, Yu H Mol Cancer. 2024; 23(1):124.

PMID: 38849840 PMC: 11157765. DOI: 10.1186/s12943-024-02016-9.


Measurement of adhesion and traction of cells at high yield (MATCHY) reveals an energetic ratchet driving nephron condensation.

Liu J, Prahl L, Huang A, Hughes A bioRxiv. 2024; .

PMID: 38370771 PMC: 10871361. DOI: 10.1101/2024.02.07.579368.


Regulation of ciliary homeostasis by intraflagellar transport-independent kinesins.

Li L, Ran J Cell Death Dis. 2024; 15(1):47.

PMID: 38218748 PMC: 10787775. DOI: 10.1038/s41419-024-06428-9.


Rho/ROCK activity tunes cell compartment segregation and differentiation in nephron-forming niches.

Viola J, Liu J, Huang A, Grindel S, Prahl L, Hughes A bioRxiv. 2023; .

PMID: 37986773 PMC: 10659296. DOI: 10.1101/2023.11.08.566308.


References
1.
Zhang Y, Conti M, Malide D, Dong F, Wang A, Shmist Y . Mouse models of MYH9-related disease: mutations in nonmuscle myosin II-A. Blood. 2011; 119(1):238-50. PMC: 3251230. DOI: 10.1182/blood-2011-06-358853. View

2.
Genovese G, Friedman D, Ross M, Lecordier L, Uzureau P, Freedman B . Association of trypanolytic ApoL1 variants with kidney disease in African Americans. Science. 2010; 329(5993):841-5. PMC: 2980843. DOI: 10.1126/science.1193032. View

3.
Nishinakamura R, Matsumoto Y, Nakao K, Nakamura K, Sato A, Copeland N . Murine homolog of SALL1 is essential for ureteric bud invasion in kidney development. Development. 2001; 128(16):3105-15. DOI: 10.1242/dev.128.16.3105. View

4.
Seri M, Cusano R, Gangarossa S, Caridi G, Bordo D, Lo Nigro C . Mutations in MYH9 result in the May-Hegglin anomaly, and Fechtner and Sebastian syndromes. The May-Heggllin/Fechtner Syndrome Consortium. Nat Genet. 2000; 26(1):103-5. DOI: 10.1038/79063. View

5.
Kopp J, Smith M, Nelson G, Johnson R, Freedman B, Bowden D . MYH9 is a major-effect risk gene for focal segmental glomerulosclerosis. Nat Genet. 2008; 40(10):1175-84. PMC: 2827354. DOI: 10.1038/ng.226. View